Growth Metrics

Catalyst Pharmaceuticals (CPRX) Enterprise Value (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.58%
Dec 31, 2025 -2.79%
Sep 30, 2025 -5.68%
Jun 30, 2025 -12.42%
Mar 31, 2025 -12.19%
Dec 31, 2024 -17.01%
Sep 30, 2024 -17.74%
Jun 30, 2024 -21.03%
Mar 31, 2024 -125.53%
Dec 31, 2023 -13.78%
Sep 30, 2023 32.34%
Jun 30, 2023 -20.60%
Mar 31, 2023 50.32%
Dec 31, 2022 -16.53%
Sep 30, 2022 -15.98%
Jun 30, 2022 -11.62%
Mar 31, 2022 -3.41%
Dec 31, 2021 -9.42%
Sep 30, 2021 -12.57%
Jun 30, 2021 -8.36%
Mar 31, 2021 -2.15%
Dec 31, 2020 -10.36%
Sep 30, 2020 -10.48%
Jun 30, 2020 -13.07%
Mar 31, 2020 -7.65%
Dec 31, 2019 -23.48%
Sep 30, 2019 -27.74%
Jun 30, 2019 -31.31%
Mar 31, 2019 14.68%
Dec 31, 2018 13.27%
Sep 30, 2018 9.86%
Jun 30, 2018 12.23%
Mar 31, 2018 7.23%
Dec 31, 2017 -147.78%
Sep 30, 2017 3.49%
Jun 30, 2017 3.82%
Mar 31, 2017 9.60%
Dec 31, 2016 -121.94%
Sep 30, 2016 59.77%
Jun 30, 2016 -74.42%
Mar 31, 2016 18.80%
Dec 31, 2015 12.38%
Sep 30, 2015 10.92%
Jun 30, 2015 9.11%
Mar 31, 2015 -26.66%
Dec 31, 2014 5.76%
Sep 30, 2014 -103.79%
Jun 30, 2014 -286.91%
Mar 31, 2014 75.71%
Dec 31, 2013 16.67%
Sep 30, 2013 -221.14%
Jun 30, 2013 -1,039.48%
Mar 31, 2013 92.75%
Dec 31, 2012 25.55%
Sep 30, 2012 -59.34%
Jun 30, 2012 -59.12%
Mar 31, 2012 21.67%
Dec 31, 2011 -45.10%
Sep 30, 2011 23.16%
Jun 30, 2011 21.31%
Mar 31, 2011 -25.52%
Dec 31, 2010 12.36%